Drugs / COL-1620
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01863680 | Jul 2013 → Oct 2014 | — | Merck KGaA, Darmstadt, Germany | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | COL-1620 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01863680 ↗ |